10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
THERMO FISHER SCIENTIFIC INC. | ||
Ticker: TMO Fiscal Year: 2021 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 24, 2022) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2021 | Dec 31, 2020 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 4,477 | 10,325 |
| Accounts receivable, less allowances of $150 and $135 | 7,977 | 5,741 |
| Inventories | 5,051 | 4,029 |
| Contract assets, net | 968 | 731 |
| Other current assets | 1,640 | 1,131 |
| Total current assets | 20,113 | 21,957 |
| Property, plant and equipment, net | 8,333 | 5,912 |
| Acquisition-related intangible assets, net | 20,113 | 12,685 |
| Other assets | 4,640 | 2,457 |
| Goodwill | 41,924 | 26,041 |
| Total assets | 95,123 | 69,052 |
| Liabilities, redeemable noncontrolling interest and equity | ||
| Current liabilities: | ||
| Short-term obligations and current maturities of long-term obligations | 2,537 | 2,628 |
| Accounts payable | 2,867 | 2,175 |
| Accrued payroll and employee benefits | 2,427 | 1,916 |
| Contract liabilities | 2,655 | 1,271 |
| Other accrued expenses | 2,950 | 2,314 |
| Total current liabilities | 13,436 | 10,304 |
| Deferred income taxes | 3,837 | 1,794 |
| Other long-term liabilities | 4,540 | 3,330 |
| Long-term obligations | 32,333 | 19,107 |
| Commitments and Contingencies | ||
| Redeemable noncontrolling interest | 122 | 0 |
| Equity: | ||
| Thermo Fisher Scientific Inc. shareholders equity: | ||
| Preferred stock, $100 par value, 50,000 shares authorized; none issued | ||
| Common stock, $1 par value, 1,200,000,000 shares authorized; 439,154,741 and 437,088,297 shares issued | 439 | 437 |
| Capital in excess of par value | 16,174 | 15,579 |
| Retained earnings | 35,431 | 28,116 |
| Treasury stock at cost, 44,720,112 and 40,417,789 shares | (8,922) | (6,818) |
| Accumulated other comprehensive items | (2,329) | (2,807) |
| Total Thermo Fisher Scientific Inc. shareholders equity | 40,793 | 34,507 |
| Noncontrolling interests | 62 | 10 |
| Total equity | 40,855 | 34,517 |
| Total liabilities, redeemable noncontrolling interest and equity | 95,123 | 69,052 |
| External Links | |
| THERMO FISHER SCIENTIFIC INC. (TMO) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |